News

Johnson & Johnson Pharmaceutical Research & Development (J&JPRD)has submitted a New Drug Application (NDA) to the FDA for Tapentadol extended release (ER) tablets. Tapentadol is an investigational oral

The Chinese State Food and Drug Administration (SFDA) has approved Bayer Schering Pharma’s Betaferon (interferon beta-1b) therapy for patients with relapsing-remitting multiple sclerosis (MS). Bayer plans to launch

Tianyin Pharmaceutical (Tianyin) has received approvals from the Chinese State Food and Drug Administration (SFDA) to produce pediatric fever and cough oral liquid in dosage form of 10ml/tube

Sartorius Stedim Biotech has inroduced FlexAct, a system for pre-configured single-use solutions to meet process requirements. FlexAct will enable biomanufacturers to utilise integrated single-use equipment for biomanufacturing steps

The Medicines Company has received European approval for the use of Angiox (bivalirudin) as an anticoagulant in patients with heart attacks (ST-segment elevation myocardial infarction (STEMI)) undergoing emergency

Provectus has presented preliminary data for PH-10 Phase 2 clinical trial for psoriasis as well as for its Phase 2 clinical trial for atopic dermatitis. According to the

China Sky One Medical (the Company) has entered into distribution agreement with Guangdong Mediacy Kind (MDK) engaging MDK to serve as its exclusive sales agent for the company’s

Genetic Analysis has launched GA-map microarray test for high throughput screening of infant gut microbiota. The company presented data from evaluation screens that show its potential as a

Genzyme has initiated shipping vials of newly produced Cerezyme (imiglucerase for injection) manufactured at Allston Landing plant. The company also provided an update on its progress to restore